Given its role in supporting tumor cell survival, ATF6 represents a potential therapeutic target. Inhibiting ATF6 activity could sensitize cancer cells to ER stress, leading to increased apoptosis and reduced tumor growth. Researchers are exploring small molecules and other strategies to inhibit ATF6, aiming to develop novel cancer therapies that exploit the vulnerability of cancer cells to ER stress.
